XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.1

Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Stockholders Equity Note [Abstract] |
Summary of the Warrants | As of March 31, 2023, the Company had 43,590,201 outstanding warrants to purchase Class A common stock. A summary of the warrants is as follows:
|  | Number of shares |  |  | Exercise price |  |  |  | Expiration date
Dragasac Warrant |  |  | 6,529,818 |  |  | $ | 6.77 |  | * |  | March 16, 2025
Public Warrants |  |  | 14,374,488 |  |  | $ | 11.50 |  |  |  | July 16, 2026
Sponsor Warrants |  |  | 8,499,999 |  |  | $ | 11.50 |  |  |  | July 16, 2026
May 2022 PIPE Warrants |  |  | 4,054,055 |  |  | $ | 8.25 |  | ** |  | May 20, 2027
March 2023 PIPE Warrants |  |  | 9,381,841 |  |  | $ | 3.00 |  |  |  | March 27, 2028
March 2023 Loan Warrants |  |  | 750,000 |  |  | $ | 0.71 |  |  |  | March 17, 2028
|  |  | 43,590,201 |  |  |  |  |  |  |
* The exercise price is the lessor of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering. ** The exercise price was amended to $0.75 effective April 10, 2023 in connection with the registered direct offering. The expiration date was also amended to be five and one-half years following the closing of the offering or October 10, 2028. Refer to Note 16 for additional information regarding subsequent events.

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration